| Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging Y Jiang, X Zhou, FC Ip, P Chan, Y Chen, NCH Lai, K Cheung, RMN Lo, ... Alzheimer's & Dementia 18 (1), 88-102, 2022 | 106 | 2022 |
| Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population X Zhou, Y Chen, FCF Ip, NCH Lai, YYT Li, Y Jiang, H Zhong, Y Chen, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 30 | 2020 |
| An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease Y Jiang, X Zhou, HY Wong, L Ouyang, FCF Ip, VMN Chau, SF Lau, W Wu, ... Nature aging 2 (7), 616-634, 2022 | 29 | 2022 |
| Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction X Zhou, Y Chen, FCF Ip, Y Jiang, H Cao, G Lv, H Zhong, J Chen, T Ye, ... Communications Medicine 3 (1), 49, 2023 | 27 | 2023 |
| The VCAM1–ApoE pathway directs microglial chemotaxis and alleviates Alzheimer’s disease pathology SF Lau, W Wu, HY Wong, L Ouyang, Y Qiao, J Xu, JHY Lau, C Wong, ... Nature Aging 3 (10), 1219-1236, 2023 | 26 | 2023 |
| A blood‐based multi‐pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups Y Jiang, H Uhm, FC Ip, L Ouyang, RMN Lo, EYL Cheng, X Cao, CMC Tan, ... Alzheimer's & Dementia 20 (3), 2000-2015, 2024 | 7 | 2024 |
| Blood transcriptome analysis for Alzheimer’disease in Hong Kong Chinese population H Zhong, X Zhou, Y Jiang, Y Chen, NCH Lai, EPS Tong, RMN Lo, ... Alzheimer's & Dementia 17, e056643, 2021 | 2 | 2021 |
| Deep learning methods improve polygenic risk analysis and prediction for Alzheimer’s disease X Zhou, Y Chen, F Ip, Y Jiang, H Cao, H Zhong, J Chen, T Ye, Y Chen, ... Commun. Med.(Lond) 3, 49, 2021 | 2 | 2021 |
| Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratification H Zhong, X Zhou, H Uhm, Y Jiang, H Cao, Y Chen, TTW Mak, RMN Lo, ... Alzheimer's & Dementia 20 (4), 2469-2484, 2024 | 1 | 2024 |
| Using deep learning models to examine the biological impact of polygenic risks for Alzheimer’s disease X Zhou, FCF Ip, G Lv, Y JIANG, H Cao, H Zhong, L Chen, AKY Fu, NY Ip Alzheimer's & Dementia 19, e065377, 2023 | 1 | 2023 |
| Identification of high‐performance blood‐based biomarkers for early screening and staging of Alzheimer’s disease by large‐scale plasma proteomic profiling in mild cognitive … Y JIANG, H Uhm, FCF Ip, RMN Lo, X Cao, CMC Tan, BCH Law, ... Alzheimer's & Dementia 20 (Suppl 2), e086052, 2025 | | 2025 |
| Development of a robust blood‐based multi‐pathway biomarker assay for early screening and classification of Alzheimer’s disease L Ouyang, Y Jiang, H Uhm, FCF Ip, RMN Lo, EYL Cheng, X Cao, ... Alzheimer's & Dementia 20 (Suppl 2), e086053, 2025 | | 2025 |
| Compositions and methods for treating alzheimer's disease NYY Ip, KY Fu, FCF Ip, Y Jiang, Z Xiaopu, L Ouyang, HY Wong, Y Duan US Patent App. 18/577,072, 2024 | | 2024 |
| Development of Blood-based Biomarkers for Assessment of Alzheimer's Disease H Zetterberg, Y JIANG Alzheimer's Association International Conference, 2024 | | 2024 |
| Transethnic analysis identifies SORL1 variants and haplotypes protective against Alzheimer's disease X Zhou, H Cao, Y Jiang, Y Chen, H Zhong, WY Fu, RMN Lo, BWY Wong, ... Alzheimer's & Dementia, 2024 | | 2024 |
| Protein markers for assessing alzheimer's disease NY Ip, KY Fu, Y JIANG, Z Xiaopu, FCF Ip US Patent App. 17/996,498, 2023 | | 2023 |
| An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE‐ε4 in Alzheimer’s disease Y JIANG, X Zhou, HY Wong, O Li, FCF Ip, VMN Chau, SF Lau, W Wu, ... Alzheimer's & Dementia 19, e064428, 2023 | | 2023 |
| An IL1RL1 genetic variant lowers soluble ST2 levels and attenuates the impact of APOE-ε4 in Alzheimer's disease Y Jiang, X Zhou, HY Wong, L Ouyang, FCF Ip, MN Chau, SF Lau, W Wu, ... | | 2022 |
| A high‐performance biomarker panel for Alzheimer’s disease screening and staging identified by large‐scale plasma proteomic profiling Y Jiang, X Zhou, FCF Ip, P Chan, Y Chen, NCH Lai, K Cheung, RMN Lo, ... Alzheimer's & Dementia 17, e056099, 2021 | | 2021 |
| Deep learning for polygenic score analysis for Alzheimer’s disease risk prediction in the Chinese population X Zhou, Y Chen, FCF Ip, Y Jiang, H Cao, H Zhong, Y Chen, J Chen, ... Alzheimer's & Dementia 17, e056625, 2021 | | 2021 |
Nancy Y IpThe Hong Kong University of Science and Technology在 ust.hk 的电子邮件经过验证
